Literature DB >> 12183834

Decreased stroma adhesion capacity of CD34+ progenitor cells from mobilized peripheral blood is not lineage- or stage-specific and is associated with low beta 1 and beta 2 integrin expression.

Alexandra Carion1, Jorge Domenech, Olivier Hérault, Lotfi Benboubker, Nathalie Clément, Marie-Christine Bernard, Isabelle Desbois, Philippe Colombat, Christian Binet.   

Abstract

Molecular mechanisms leading to mobilization of hematopoietic cells from bone marrow (BM) to peripheral blood (PB) involve modulation of adhesion molecule expression on these cells that probably result in changes in adhesion capacity to the microenvironment. However, it is not clear whether these changes involve different stages or lineages of progenitor cells. In this study, we compared the capacity of mature and immature clonogenic progenitor cells from granulocyte colony-stimulating factor (G-CSF)-mobilized PB and normal BM CD34+ cells to adhere to complete marrow stroma. This functional capacity was assessed concurrently with molecular expression on CD34+ cells of integrins VLA-4 (alpha 4/beta 1), VLA-5 (alpha 5/beta 1), and LFA-1 (alpha L/beta 2) by interindividual (between mobilized PB and normal BM) and intraindividual (between mobilized PB and steady-state BM and PB in the same patient) analysis. The proportion of adherent clonogenic progenitor cells was significantly lower in PB than in BM, not only for total progenitor cells but also for mature and immature progenitor cells, and the difference was found for granulocytic and particularly for erythroid lineages. The lower adhesion capacity of PB CD34+ cells to stroma was associated with decreased expression (signal/noise MFI ratio) of integrin alpha 4, beta 1, alpha L, and beta 2 chains whereas that of alpha 5 chain did not differ from BM cells with the lowest expression level. Similar differences in integrin expression levels were also found between mobilized PB and steady-state BM CD34+ cells in the same patient except for the alpha L chain. Moreover, we demonstrated for the first time a strong positive correlation between mobilizing capacity and expression levels on mobilized CD34+ cells for the LFA-1 alpha L chain but not for VLA-4 or VLA-5. In conclusion, the decreased adhesion capacity of mobilized PB progenitor cells to stroma involves different maturation stages and different lineages. This is associated with down-regulation of integrins VLA-4 and LFA-1, but mobilizing capacity appears positively correlated with LFA-1 levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183834     DOI: 10.1089/15258160260090951

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  4 in total

1.  Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.

Authors:  Fernanda Marconi Roversi; Matheus Rodrigues Lopes; João Agostinho Machado-Neto; Ana Leda F Longhini; Adriana da Silva Santos Duarte; Mariana Ozello Baratti; Bruna Palodetto; Flávia Adolfo Corrocher; Fernando Vieira Pericole; Paula de Melo Campos; Patricia Favaro; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Stem Cells Dev       Date:  2014-02-18       Impact factor: 3.272

2.  Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.

Authors:  P Szumilas; K Barcew; M Baśkiewicz-Masiuk; B Wiszniewska; M Z Ratajczak; B Machaliński
Journal:  Cell Prolif       Date:  2005-02       Impact factor: 6.831

3.  In vitro endothelialization of electrospun terpolymer scaffolds: evaluation of scaffold type and cell source.

Authors:  Daniel E Heath; Christopher Kobe; Desiree Jones; Nicanor I Moldovan; Stuart L Cooper
Journal:  Tissue Eng Part A       Date:  2012-09-04       Impact factor: 3.845

4.  Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.

Authors:  Fernanda Marconi Roversi; Nathalia Moreno Cury; Matheus Rodrigues Lopes; Karla Priscila Ferro; João Agostinho Machado-Neto; Marisa Claudia Alvarez; Gabriela Pereira Dos Santos; Renata Giardini Rosa; Ana Leda Longhini; Adriana da Silva Santos Duarte; Fernando Vieira Pericole; Patricia Favaro; José Andres Yunes; Sara Teresinha Olalla Saad
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.